Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants.

Antifungal stewardship Critically ill patients Fluconazole Pharmacokinetic Therapeutic drug monitoring

Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 12 09 2022
revised: 19 10 2022
accepted: 24 10 2022
pubmed: 4 11 2022
medline: 9 3 2023
entrez: 3 11 2022
Statut: ppublish

Résumé

This study aims at evaluating fluconazole exposure in critically ill patients and identifying variables associated with the latter. This was a 2-year (2018-2019) retrospective multicenter cohort study. Adult patients > 18 years-old with at least one fluconazole concentration measurement during their ICU stay were included. Twenty patients were included. Only 11 patients had a fluconazole trough concentration (Cmin) within the target range (≥15 mg/L). According to bivariable analysis, SOFA score, GGT, fluconazole clearance, Ke, and Vd, were independently associated with a decrease in fluconazole Cmin. The median loading dose required to achieve the Cmin target appeared to be greater in patients with higher SOFA or GGT level and in patients undergoing renal replacement therapy. This study supports recommendation for routine fluconazole therapeutic drug monitoring in ICU patients so as to avoid underexposure, especially if SOFA score is ≥ 7 and/or GGT is ≥ 100 U/L.

Identifiants

pubmed: 36328312
pii: S2666-9919(22)00231-7
doi: 10.1016/j.idnow.2022.10.002
pii:
doi:

Substances chimiques

Fluconazole 8VZV102JFY
Antifungal Agents 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104630

Investigateurs

Florence Ader (F)
Laurent Argaud (L)
Frédéric Aubrun (F)
Jean-Luc Fellahi (JL)
Céline Guichon (C)
Laurent Juillard (L)
Vincent Leclerc (V)
Charline Miossec (C)
Carole Paillet (C)
Alexandra Plesa (A)
Jean-Christophe Richard (JC)
Sandrine Roux (S)
Florent Wallet (F)

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

A L Bienvenu (AL)

Service Pharmacie, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France; ICBMS CNRS 5246, Campus Lyon-Tech La Doua, Université de Lyon, Lyon, France. Electronic address: anne-lise.bienvenu@chu-lyon.fr.

P Pradat (P)

Centre de Recherche Clinique, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France.

E Matusik (E)

Service Pharmacie, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France.

V Piriou (V)

Service d'anesthésie-réanimation, Groupement Hospitalier Sud, Hospices Civils de Lyon, Lyon, France.

T Rimmelé (T)

Service d'anesthésie-réanimation, Groupement Hospitalier Centre, Hospices Civils de Lyon, Lyon, France.

F Parant (F)

Laboratoire de Biochimie et Biologie Moléculaire, UM Pharmaco-toxicologie Groupement Hospitalier Sud, Hospices Civils de Lyon, Lyon, France.

M Tod (M)

Service Pharmacie, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France; Univ Lyon, Université Lyon 1, ISPB, Faculté de Pharmacie de Lyon, Lyon, France; Univ Lyon, Université Lyon 1 UMR CNRS 5558, Laboratoire de Biométrie et Biologie Evolutive, Villeurbanne, France.

G Leboucher (G)

Service Pharmacie, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France.

S Goutelle (S)

Service Pharmacie, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France; Univ Lyon, Université Lyon 1, ISPB, Faculté de Pharmacie de Lyon, Lyon, France; Univ Lyon, Université Lyon 1 UMR CNRS 5558, Laboratoire de Biométrie et Biologie Evolutive, Villeurbanne, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH